Focal low-dose rate brachytherapy for the treatment of prostate cancer

Whole-gland low-dose rate (LDR) brachytherapy has been a well-established modality of treating low-risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. Focal treatment using LDR brachytherapy has been relatively unexplored, but it may offer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, William Y, Cohen, Gilad, Yamada, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775638/
https://www.ncbi.nlm.nih.gov/pubmed/24049459
http://dx.doi.org/10.2147/CMAR.S33056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775638/
https://www.ncbi.nlm.nih.gov/pubmed/24049459
http://dx.doi.org/10.2147/CMAR.S33056

Ejemplares similares